Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 348

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 348
---
 option activity for the three months ended March 31, 2025:

|                                  |     | Number     
 of options |           |   |     | WeightedAverageExercise Price |      |     | WeightedAverageContractual Life |            |
|:---------------------------------|:----|:-----------|----------:|:--|:----|:------------------------------|-----:|:----|:--------------------------------|:-----------|
| Outstanding at December 31, 2024 |     |            | 6,403,818 |   |     | $                             | 5.11 |     |                                 | 7.44 years |
| Forfeited and cancelled          |     |            |  (131,193 | ) |     | $                             | 3.69 |     |                                 |            |
| Exercised                        |     |            |  (266,486 | ) |     | $                             | 2.09 |     |                                 |            |
| Granted                          |     |            |   505,298 |   |     | $                             | 3.39 |     |                                 |            |
| Outstanding at March 31, 2025    |     |            | 6,511,437 |   |     | $                             | 5.13 |     |                                 | 7.44 years |
| Exercisable at March 31, 2025    |     |            | 2,171,521 |   |     | $                             | 6.08 |     |                                 | 3.81 years |

Options outstanding had an intrinsic value of $ 1,183,000 and $ 5,494,000 as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025, there was approximately $ 14,000,000 of unrecognized stock compensation, which will be recognized over the next three years .

Stock compensation expense

Total stock-based compensation expense for the three months ended March 31, 2025 and 2024 was allocated as follows:

|                                        |     |   |      2025 |     |   |    2024 |
|:---------------------------------------|:----|:--|----------:|:----|:--|--------:|
| General and administrative             |     | $ |   488,646 |     | $ | 207,703 |
| Research and development               |     |   |   936